The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells

Chemico-Biological Interactions

Volumn 116, Issue 3, 1998, Pages 213-228

  Rodgers, E Hazel ^a   Grant, M Helen ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Anti tumour effects; Flavonoids; MCF7 human breast cancer cells; Xenobiotic metabolising enzymes

Indexed keywords

EPICATECHIN; FLAVONOID; MYRICETIN; QUERCETIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DIET; DNA SYNTHESIS; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; METABOLIC ACTIVATION; MORPHOLOGY; XENOBIOTIC METABOLISM;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CATECHIN; CELL DIVISION; FLAVONOIDS; GLUTATHIONE; HUMANS; L-LACTATE DEHYDROGENASE; NEOPLASM PROTEINS; OXIDATION-REDUCTION; QUERCETIN; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0031724702     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(98)00092-1     Document Type: Article

References (37)

1. Obermeier M.T., White R.E., Yang C.S. Effects of bioflavonoids on hepatic P450 activities. Xenobiotica. 25:1995;575-584.
2. Buening M.K., Chang R.L., Huang M.-T., Fortner J.G., Wood A.W., Conney A.H. Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res. 41:1981;67-72.
3. Lasker J.M., Huang M.-T., Conney A.H. In vitro and in vivo activation of oxidative drug metabolism by flavonoids. J. Pharmacol. Exp. Ther. 229:1984;162-170.
4. Siess M.-H., Guillermic M., Le Bon A.-M., Suschetet M. Induction of monoxygenase and transferase activities in rat by dietary administration of flavonoids. Xenobiotica. 19:1989;1379-1386.
5. Siess M.-H., Pennec A., Gaudou E. Inhibition of ethoxy- and pentoxy-resorufin dealkylases of rat liver by flavones and flavonols: Structure-activity relationship. Eur. J. Drug Metab. Pharmacokinet. 14:1989;235-239.
6. E. Middleton, C. Kandaswami, The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer, in: J.B. Harborne (Ed.), The Flavonoids: Advances in Research since 1986, Chapman & Hall, London, 1993, pp. 619-652.
7. Walle T., Eaton E.A., Walle U.K. Quercetin, a potent and specific inhibitor of the human P-form phenolsulfotransferase. Biochem. Pharmacol. 50:1995;731-734.
8. Prochaska H.J., Talalay P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res. 48:1988;4776-4782.
9. Li S.J., Rodgers E.H., Grant M.H. The activity of xenobiotic enzymes and the cytotoxicity of mitoxantrone in MCF7 human breast cancer cells treated with inducing agents. Chem.-Biol. Interact. 97:1995;101-118.
10. Hissin P.J., Hilf R. A fluorimetric method for determination of oxidised and reduced glutathione in tissues. Anal. Biochem. 74:1976;214-226.
11. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
12. Anuforo D.C., Acosta D., Smith R.V. Hepatotoxicity studies with primary cultures of rat liver cells. In Vitro. 14:1978;981-988.
13. Macnair R., Rodgers E.H., MacDonald C., Wykman A., Goldie I., Grant M.H. The response of primary rat and human osteoblasts and an immortalised rat osteoblast cell line to orthopaedic materials: comparative sensitivity of several toxicity indices. J. Mater. Sci. Mater. Med. 8:1997;105-111.
14. Grant M.H., Duthie S.J., Gray A.G., Burke M.D. Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line. Biochem. Pharmacol. 37:1988;4111-4116.
15. Lind C., Hojeberg B. Biospecific adsorption of hepatic DT-diaphorase on immobilised dicoumarol. Purification of mitochondrial and microsomal DT-diaphorase from 3-methylcholanthrene treated rats. Arch. Biochem. Biophys. 207:1981;217-223.
16. Phillips A.H., Langdon R.G. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterisation and kinetic studies. J. Biol. Chem. 237:1962;2652-2660.
17. Carlberg I., Mannervik B. Glutathione reductase. Methods Enzymol. 113:1985;484-490.
18. Hertog M.G.L., Hollman P.C.H., Katan M.B., Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer. 20:1993;21-29.
19. Musonda C.A., Helsby N., Chipman J.K. Effects of quercetin on drug metabolizing enzymes and oxidation of 2′,7-dichlorofluorescin in Hep G2 cells. Hum. Exp. Toxicol. 16:1997;700-708.
20. Scambia G., Ranelletti F.O., Panici P.B., Piantelli M., Bonanno G., De Vincenzo R., Ferrandina G., Pierelli L., Capelli A., Mancuso S. Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites. Cancer Chemother. Pharmacol. 28:1991;255-258.
21. Yanagihara K., Ito A., Toge T., Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 53:1993;5815-5821.
22. Ferry D.R., Smith A., Malkhandi J., Fyfe D.W., deTakats P.G., Anderson D., Baker J., Kerr D.J. Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 2:1996;659-668.
23. Srivastava A.K. Inhibition of phosphorylase kinase and tyrosine protein kinase activities by quercetin. Biochem. Biophys. Res. Commun. 131:1985;1-5.
24. Wei Y.-Q., Zhou Y., Kariya Y., Fukata H., Teshigawara K., Uchida A. Induction of apoptosis by quercetin: Involvement of heat shock proteins. Cancer Res. 54:1994;4952-4957.
25. Avila M.A., Velasco J.A., Cansado J., Notario V. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res. 54:1994;2424-2428.
26. Matter W.F., Brown R.F., Vlahos C.J. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogues. Biochem. Biophys. Res. Commun. 186:1992;624-631.
27. Melkonian A.D., Gaylor J.D.S., Cousins R.B., Grant M.H. Culture of a differentiated liver cell line, Hep G2, in serum with application to a bioartificial liver: the effect of supplementation of serum with amino acids. Artif. Organs. 18:1994;611-617.
28. Ioannides C., Parke D.V. Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis. Drug Metab. Rev. 25:1993;485-501.
29. Siess M.-H., Leclerc J., Canivenc-Lavier M.-C., Rat P., Suschetet M. Heterogenous effects of natural flavonoids on monooxygenase activities in human and rat liver microsomes. Toxicol. Appl. Pharmacol. 130:1995;73-78.
30. Li Y., Wang E., Patten C.J., Chen L., Yang C.S. Effects of flavonoids on cytochrome P450-dependent acetaminophen metabolism in reductaseats and human liver microsomes. Drug Metab. Dispos. 22:1994;566-571.
31. Bailey D.G., Arnold J.M.O., Munoz C., Spence J.D. Grapefruit juice-felodipine interaction: Mechanism, predictability, and effect of naringin. Clin. Pharmacol. Ther. 53:1993;637-642.
32. Fuhr U., Klittich K., Staib A.H. Inhibitory effect of grapefruit juice and the active component naringenin on CYP1A2 dependent metabolism of caffeine in man. Br. J. Pharmacol. 35:1993;431-436.
33. Rashid J., McKinstry C., Renwick A.G., Dirnhuber M., Waller D.G., George C.F. Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice. Br. J. Clin. Pharmacol. 36:1993;460-463.
34. Williamson G., Plumb G.W., Uda Y., Price K.R., Rhodes M.J.C. Dietary quercetin glycosides: antioxidant activity and induction of the anticarcinogenic phase II marker enzyme quinone reductase in Hepalclc7 cells. Carcinogenesis. 17:1996;2385-2387.
35. Zhang K., Wong K.P. Glutathione conjugation of chlorambucil: Measurement and modulation by plant polyphenols. Biochem. J. 325:1997;417-422.
36. Teofili L., Pierelli L., Iovino S., Leone G., Scambia G., De Vincenzo R., Benedetti-Panici P., Menichella G., Marci E., Piantelli M., Ranaletti F.O., Larocca L.M. The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth. Leuk. Res. 16:1992;479-503.
37. Hoffmann J., Fiebig H.H., Winterhalter B.R., Berger D.P., Grunicke H. Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin. Int. J. Cancer. 45:1990;536-539.